This live simulcast out of Sydney Australia, is jointly sponsored by St. Vincent’s Health Australia and GlobalCastMD. The topics will cover contemporary imaging of the prostate, the role of focal therapy and optimizing biopsy techniques. The course format will include live surgeries, debate and interaction from the participants in true GlobalCastMD style. The show begins at 8AM ADT. This is 6PM Eastern Daylight Time (New York)
The format will include brief overviews of contemporary imaging of the prostate, focal therapy and optimizing biopsy techniques followed by lively debate fueled by a panel of key opinion leaders worldwide. Surgical cases of the HIFU and Irreversable Electroporation will be broadcasted live. As with all of our courses, the audience will be able to participate and ask questions.
Associate Professor Phillip Stricker is one of the leading experts in the treatment of prostate cancer in Australia . He is Chairman of the Department of Urology at St Vincent’s Campus, the Director of the St Vincent’s Prostate Cancer Centre, Clinical Director of The Prostate Cancer Programme at the Kinghorn Cancer Centre.
Mark Emberton holds the post of professor in interventionaloncology at University College London and is associate professor at MiddlesexUniversity, London. At UCLH he is pathway director for urological cancer for UCLPartners. He is also honorary clinical director of the ClinicalEffectiveness Unit at the Royal College of Surgeons of England. Prof Emberton's clinical and research interests are focused mainly on diseases of the prostategland, both benign and malignant. In prostate cancer much of his activity is at presentfocused on evaluating minimally invasive therapies for localised prostatecancer.
Associate Professor Nathan Lawrentschuk is a Urologist/Urologic Oncologist at University of Melbourne and Ludwig Institute for Cancer Research.
Dr Daniel Moses, BSc(Hons) MBBS(Hons) FRANZCR ABR(Certified) currently holds senior staff specialist positions at Liverpool Hospital and Prince of Wales/Sydney Children's Hospital.
Associate Prof Declan Murphy is a consultant urological surgeon at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, and Director of Outcomes Research and Risk Stratification at the Australian Prostate Cancer Research Centre, Director of Robotic Surgery at Peter Mac. Declan is honorary clinical Associate Professor at the University of Melbourne and co-director of the Fellowship programme at Royal Melbourne and the Peter MacCallum Cancer Centre.
Dr. Lee Ponsky is an Associate Professor Urology, Leo & Charlotte Goldberg Chair in Advanced Surgical Therapies and the Director, Urology Institute Division of Oncology at University Hospitals Case Medical Center, Cleveland, Ohio, United States.
Dr. Ron Shnier, MBBS FRANZCR ANZAPNM is clinical director of MRI at NeuroscienceAustralia and director of MRI services for Southern Radiology.
Dr. Les Thompson is an Urologist with experience across all aspects of urological surgery and a particular interest in urological cancer surgery who commenced at the Wesley in 1986. Dr Thompson holds a Bachelor of Medicine and Bachelor of Surgery (MBBS) (Hons), and is a Fellow of the Royal Australasian College of Surgeons (FRACS). Dr Thompson is also a Member of the Urological Society of Australia and New Zealand, Societie International de Urologie, and the Australian Medical Association.
